Open main menu

Wikipedia β

Vitamin E refers to a group of compounds that include both tocopherols and tocotrienols.[1][2] Of the many different forms of vitamin E, γ-tocopherol is the most common form found in the North American diet.[3] γ-Tocopherol can be found in corn oil, soybean oil, margarine, and dressings.[3][4] α-tocopherol, the most biologically active form of vitamin E, is the second-most common form of vitamin E in the diet. This variant can be found most abundantly in wheat germ oil, sunflower, and safflower oils.[3][5] As a fat-soluble antioxidant, it interrupts the propagation of reactive oxygen species that spread through biological membranes or through a fat when its lipid content undergoes oxidation by reacting with more-reactive lipid radicals to form more stable products.[3][6][1] Regular consumption of more than 1,000 mg (1,500 IU) of tocopherols per day[1] may be expected to cause hypervitaminosis E, with an associated risk of vitamin K deficiency and consequently of bleeding problems.

Vitamin E
Drug class
Tocopherol, alpha-.svg
The α-tocopherol form of vitamin E
Class identifiers
Use Vitamin E deficiency, antioxidant
ATC code A11H
Biological target Reactive oxygen species
Clinical data MedFacts Natural Products
External links
MeSH D014810
In Wikidata



The nutritional content of vitamin E is defined by α-tocopherol activity. The molecules that contribute α-tocopherol activity are four tocopherols and four tocotrienols, identified by the prefixes alpha- (α-), beta- (β-), gamma- (γ-), and delta- (δ-).[7] Natural tocopherols occur in the RRR-configuration only. The synthetic form contains eight different stereoisomers and is called 'all-rac'-α-tocopherol.[8]


Sample of α-tocopherol, one of the various forms of vitamin E

alpha-Tocopherol is a lipid-soluble antioxidant functioning within the glutathione peroxidase pathway,[9] and protecting cell membranes from oxidation by reacting with lipid radicals produced in the lipid peroxidation chain reaction.[3][10] This removes the free radical intermediates and prevents the oxidation reaction from continuing. The oxidized α-tocopheroxyl radicals produced in this process may be recycled back to the active reduced form through reduction by other antioxidants, such as ascorbate, retinol or ubiquinol.[11] Other forms of vitamin E have their own unique properties; for example, γ-tocopherol is a nucleophile that can react with electrophilic mutagens.[12]


General chemical structure of tocotrienols. alpha(α)-Tocotrienol: R1 = Me, R2 = Me, R3 = Me; beta(β)-Tocotrienol: R1 = Me, R2 = H, R3= Me; gamma(γ)-Tocotrienol: R1 = H, R2 = Me, R3= Me; delta(δ)-Tocotrienol: R1 = H, R2 = H, R3= Me

Tocotrienols are members of the vitamin E family: four tocotrienols (alpha, beta, gamma, delta) similar in structure to the four tocopherols, with the critical difference is that tocopherols have saturated side chains whereas tocotrienols have unsaturated isoprenoid side chains with three double bonds. Preliminary clinical trials on dietary supplement tocotrienols indicate potential for anti-disease activity.[13] Tocotrienols have lower bioavailability in blood, potential for anticoagulant effects, and appear to be safe and well-tolerated.[13]


Vitamin E has many biological functions, including its role as a fat-soluble antioxidant.[1][14]

  • As an antioxidant, vitamin E acts as a peroxyl radical scavenger, disabling the production of damaging free radicals in tissues, by reacting with them to form a tocopheryl radical, which will then be reduced by a hydrogen donor (such as vitamin C) and thus return to its reduced state.[15] As it is fat-soluble, it is incorporated into cell membranes, which protects them from oxidative damage.
  • Vitamin E has also found use as a commercial antioxidant and biocompatible modifier of biomaterials and medical devices, for example in ultra high molecular weight polyethylene (UHMWPE) used in hip and knee implants by resisting oxidation [16] and in hollow-fiber membrane cartridges used in extracorporeal hemodialysis therapy.[17]
  • As an enzymatic activity regulator, for instance, protein kinase C (PKC), which plays a role in smooth muscle growth, can be inhibited by α-tocopherol. α-Tocopherol has a stimulatory effect on the dephosphorylation enzyme, protein phosphatase 2A, which in turn, cleaves phosphate groups from PKC, leading to its deactivation, bringing the smooth muscle growth to a halt.[18]
  • Vitamin E also has an effect on gene expression. Macrophages rich in cholesterol are found in atherosclerotic tissue.[19] Scavenger receptor CD36 is a class B scavenger receptor found to be up-regulated by oxidized low density lipoprotein (LDL) and binds it.[20] Treatment with α-tocopherol was found to downregulate the expression of the CD36 scavenger receptor gene and the scavenger receptor class A (SR-A)[20] and modulates expression of the connective tissue growth factor (CTGF).[21][22] The CTGF gene, when expressed, is responsible for the repair of wounds and regeneration of the extracellular tissue lost or damaged during atherosclerosis.[22]
  • Vitamin E also plays a role in eye and neurological functions,[1][23] and inhibition of platelet coagulation.[24][25][26]
  • Vitamin E also protects lipids and prevents the oxidation of polyunsaturated fatty acids.[27]

Although most vitamin E supplementation studies used α-tocopherol individually, this design of studying only one isoform of vitamin E may introduce errors in interpreting overall vitamin E effects; for example, using only α-tocopherol in studies of inflammation can reduce serum γ- and δ-tocopherol concentrations.[28] Moreover, a 2013 review involving single long-term supplementation with α-tocopherol showed that many clinical studies revealed an inverse relationship between supplementation and cardiovascular disease risk or mortality, but other studies showed no effect.[29]


Vitamin E deficiency can cause:


Vitamin E supplementation has not been shown to have significant benefit for people who are healthy, and appears to be harmful.[33][34] It does not improve blood sugar control in an unselected group of people with diabetes mellitus[35] or decrease the risk of stroke.[36] Daily supplementation of vitamin E does not decrease the risk of prostate cancer, and may increase it.[1][37] Studies on its role in age-related macular degeneration are ongoing, though if it is of a combination of dietary antioxidants used to treat the condition it may increase the risk.[38] Routine supplementation with vitamin E during pregnancy has been shown to offer no benefit to the mother or the child. Vitamin E has been reported to cause more side effects, such as abdominal pain in pregnant women, and also the increased risk of having early rupture of membranes at term.[39]

Supplementary Vitamin E, along with β-carotene and vitamin C, has shown no protective effect on reducing the risk of cataract, cataract extraction, progression of cataract, and slowing the loss of visual acuity.[40]

Topical usesEdit

Although there is widespread use of vitamin E as a topical medication, with claims for improved wound healing and reduced scar tissue, a 2015 review concluded that there is insufficient evidence to support these claims.[41]


The LD50, or the toxic dose required to kill 50% of experimental rats or mice, is 4000 mg of vitamin E per kg.[42] Vitamin E can act as an anticoagulant, increasing the risk of bleeding, specifically acting synergistically with the blood-thinner, warfarin.[1][43] As a result, the U.S. Food and Nutrition Board has set a tolerable upper intake levels (UL) at 1,000 mg (1,500 IU) per day.[1][44] Hypervitaminosis E may also counteract vitamin K, leading to a vitamin K deficiency.[citation needed] In high doses, vitamin E has prooxidant properties, possibly causing oxidation which may damage cells and increase the risk of cancer or mortality.[43] Supplementation with vitamin E is not indicated during treatment with chemotherapy or radiotherapy.[1] Long-term use of high doses may cause nausea, diarrhea, or vision deficiencies.[43]

Dietary sourcesEdit

mg/(100 g)
[note 1]
Some foods with vitamin E content[3][1][45]
low high
150 Wheat germ oil
95 Almond oil
44 Canola/rapeseed oil
41 Sunflower oil
34 Safflower oil
26 Almonds
19 Wheat germ
15 Hazelnuts
14 Olive oil
8.33 Peanut
1.5 3.4 High-value green, leafy vegetables: spinach, turnip, beet greens, collard greens, and dandelion greens[note 2]
2.32 Butter
2 Avocados
1.8 Cocoa butter
1.4 Sesame oil
1.1 1.5 Asparagus[note 3]
1.5 Kiwifruit (green)
0.90 Cashew nuts
0.78 1.5 Broccoli[note 4]
0.8 1 Pumpkin[note 5]
0.26 0.94 Sweet potato[note 6]
0.9 Mangoes
0.7 Walnuts
0.54 0.56 Tomatoes[note 7]
0.13 0.22 Low-value green, leafy vegetables: lettuce[note 8]

Dietary recommendationsEdit

The U.S. Institute of Medicine (IOM) updated Estimated Average Requirements (EARs) and Recommended Dietary Allowances (RDAs) for vitamin E in 2000. The current EAR for vitamin E for women and men ages 14 and up is 12 mg/day. The RDA is 15 mg/day. RDAs are higher than EARs so as to identify amounts that will cover people with higher than average requirements. RDA for pregnancy is 15 mg/day. RDA for lactation is 19 mg/day. For infants up to 12 months the Adequate Intake (AI) is 4-5 mg/day. For children ages 1–13 years the RDA increases with age from 6 to 11 mg/day. As for safety, the IOM sets Tolerable upper intake levels (ULs) for vitamins and minerals when evidence is sufficient. In the case of vitamin E the UL is 1000 mg/day. Collectively the EARs, RDAs, AIs and ULs are referred to as Dietary Reference Intakes (DRIs).[44]

The European Food Safety Authority (EFSA) refers to the collective set of information as Dietary Reference Values, with Population Reference Intake (PRI) instead of RDA, and Average Requirement instead of EAR. AI and UL defined the same as in United States. For women and men ages 10 and older the PRIs are set at 11 and 13 mg/day, respectively. PRI for pregnancy is 11 mg/day, for lactation 11 mg/day. For children ages 1–9 years the PRIs increase with age from 6 to 9 mg/day. These PRIs are lower than the U.S. RDAs.[46] The European Food Safety Authority reviewed the same safety question and set a UL at 300 mg/day.[47]

For U.S. food and dietary supplement labeling purposes the amount in a serving is expressed as a percent of Daily Value (%DV). For vitamin E labeling purposes 100% of the Daily Value was 30 mg, but as of May 27, 2016 it was revised to 15 mg to bring it into agreement with the RDA.[48] A table of the old and new adult Daily Values is provided at Reference Daily Intake. Food and supplement companies have until July 28, 2018 to comply with the change.


Vitamin E was discovered in 1922 by Herbert McLean Evans and Katharine Scott Bishop[49] and first isolated in a pure form by Gladys Anderson Emerson in 1935 at the University of California, Berkeley.[50] Erhard Fernholz elucidated its structure in 1938 and shortly afterwards the same year, Paul Karrer and his team first synthesized it.[51]

The first use for vitamin E as a therapeutic agent was conducted in 1938 by Widenbauer, who used wheat germ oil supplement on 17 premature newborn infants suffering from growth failure. Eleven of the original 17 patients recovered and were able to resume normal growth rates.[52]

In 1945, Drs. Evan V. Shute and Wilfred E. Shute, siblings from Ontario, Canada, published the first monograph arguing that megadoses of vitamin E can slow down and even reverse the development of atherosclerosis.[53] Peer-reviewed publications soon followed.[54][55] The same research team also demonstrated, in 1946, that α-tocopherol improved impaired capillary permeability and low platelet counts in experimental and clinical thrombocytopenic purpura.[56]

Later, in 1948, while conducting experiments on alloxan effects on rats, Gyorge and Rose noted rats receiving tocopherol supplements suffered from less hemolysis than those that did not receive tocopherol.[57] In 1949, Gerloczy administered all-rac-α-tocopheryl acetate to prevent and cure edema.[58][59] Methods of administration used were both oral, that showed positive response, and intramuscular, which did not show a response.[52] This early investigative work on the benefits of vitamin E supplementation was the gateway to curing the vitamin E deficiency-caused hemolytic anemia described during the 1960s. Since then, supplementation of infant formulas with vitamin E has eradicated this vitamin’s deficiency as a cause for hemolytic anemia.[52]

Cardiovascular diseaseEdit


Atherosclerosis is a disease condition that refers to the buildup of plaque, which is a substance containing lipid and cholesterol (mainly the low-density lipoprotein or LDL cholesterol) on the inner layer of the arterial lumen.[60] With the existing plaque, instead of being smooth and elastic, the layers become thickened and irregular and the lumen of the artery become narrower. This vessel-narrowing effect lead to a reduction of blood circulation and can lead to or worsen the condition of hypertension.[61]

There are currently multiple theories explaining factors causing and affecting the cholesterol plaque build up within arteries with the most popular theory indicating that the rate of build up is affected by the oxidation of the LDL cholesterol. LDL cholesterol is one of the five major groups of lipoproteins with one of the physiological roles being lipid transportation. A typical LDL particle contain 2,700 fatty acid molecules and half of them are poly-unsaturated fatty acids, which are very oxidation sensitive.[62] Once the oxidation of LDL occur, it will start a series of undesirable effects starting from the increase production of inflammatory cytokines by stimulating the endothelial cells and monocytes, followed by increased production of tissue factors, production of macrophages and monocytes, which eventually lead to the formation of foam cells and accelerated development of atherosclerosis. With the presence of adequate concentration of vitamin E, which is a very potent fat-soluble antioxidant, it can inhibit the oxidation of LDL, and this inhibition contributes protection against the development of atherosclerosis and can stabilize the existing plaque.[62]

Cardiovascular researchEdit

According to one meta-analysis,[63] nine cohort studies showed that high intake of tocopherol was associated with a lower risk of cardiovascular diseases compared with lower intake. In 1993, a study of 39,919 male health professionals aged 40 to 75 showed that consumption of more than 60 IU of vitamin E (any form) per day was associated with a lower incidence of coronary heart disease compared with less than 7.5 IU/day intake.[64] This study also showed an inverse association between vitamin E supplementation and the incidence of heart disease.

A 2015 systematic review of clinical trials concluded that vitamin E supplementation alone improved endothelial function as determined by measurements of forearm blood flow, but when combined with vitamin C supplementation, it did not.[65] A meta-analysis of clinical trials showed no significant association between vitamin E supplementation and cardiovascular mortality.[66]


  1. ^ "USDA Nutrient Data Laboratory".  In notes 2–11, USDA NDL Release 24 numbers are given as mg/(100 g). Low and high values vary some by raw versus cooked and by variety.
  2. ^ Spinach (2.0 raw, 2.1 cooked), turnip (2.9 raw, 1.9 cooked), beet (1.5 raw, 1.8 cooked), collard (2.3 raw, 0.88 cooked), and dandelion greens (3.4 raw, 2.4 cooked)
  3. ^ 1.1 raw, 1.5 cooked
  4. ^ 0.78 raw, 1.5 cooked
  5. ^ 1. raw, 0.8 cooked
  6. ^ 0.26 raw, 0.94 boiled
  7. ^ 0.54 raw, 0.56 cooked
  8. ^ Lettuce (0.18 iceberg, 0.22 green leaf, 0.13 romaine, 0.15 red leaf, 0.18 butterhead)


  1. ^ a b c d e f g h i j k l m n o "Vitamin E — Health Professional Fact Sheet". Office of Dietary Supplements, US National Institutes of Health. 9 May 2016. Retrieved 5 February 2015. 
  2. ^ Brigelius-Flohé R, Traber MG (1999). "Vitamin E: function and metabolism" (PDF). FASEB J. 13 (10): 1145–1155. PMID 10385606. 
  3. ^ a b c d e f "Vitamin E". Micronutrient Information Center, Linus Pauling Institute, Oregon State University, Corvallis, OR. May 2015. Retrieved 7 March 2017. 
  4. ^ Bieri JG, Evarts RP; Evarts (1974). "γ-Tocopherol: metabolism, biological activity and significance in human vitamin E nutrition". American Journal of Clinical Nutrition. 27 (9): 980–986. PMID 4472121. 
  5. ^ Reboul E, Richelle M, Perrot E, Desmoulins-Malezet C, Pirisi V, Borel P; Richelle; Perrot; Desmoulins-Malezet; Pirisi; Borel (15 November 2006). "Bioaccessibility of carotenoids and vitamin E from their main dietary sources". Journal of Agricultural and Food Chemistry. 54 (23): 8749–8755. PMID 17090117. doi:10.1021/jf061818s. 
  6. ^ Choe, Eunok; Min, David B (October 2009). "Mechanisms of Antioxidants in the Oxidation of Foods". Comprehensive Reviews in Food Science and Food Safety. 8 (4): 345–358. doi:10.1111/j.1541-4337.2009.00085.x. Retrieved 4 September 2016. 
  7. ^ Traber, M.G. "19". In Ross, A. Catherine. Modern Nutrition in Health and Disease (11 ed.). Philadelphia, PA: Lippincott Williams & Wilkins. pp. 293–294. ISBN 9781605474618. 
  8. ^ Traber, MG. "Chapter 15: vitamin E". In Bowman BA and Russell RM. Current Knowledge in Nutrition. I (9 ed.). Washington DC, USA: ILSI. ISBN 978-1-57881-199-1. 
  9. ^ Wefers H, Sies H; Sies (1988). "The protection of ascorbate and glutathione against microsomal lipid peroxidation is dependent on Vitamin E". European Journal of Biochemistry. 174 (2): 353–357. PMID 3383850. doi:10.1111/j.1432-1033.1988.tb14105.x. 
  10. ^ a b Traber MG, Atkinson J; Atkinson (2007). "Vitamin E, Antioxidant and Nothing More". Free Radical Biology & Medicine. 43 (1): 4–15. PMC 2040110 . PMID 17561088. doi:10.1016/j.freeradbiomed.2007.03.024. 
  11. ^ Wang X, Quinn PJ; Quinn (1999). "Vitamin E and its function in membranes". Progress in Lipid Research. 38 (4): 309–36. PMID 10793887. doi:10.1016/S0163-7827(99)00008-9. 
  12. ^ Brigelius-Flohé R, Traber MG; Traber (1999). "Vit amin E: function and metabolism". FASEB J. 13 (10): 1145–55. PMID 10385606. 
  13. ^ a b Meganathan P, Fu JY (2016). "Biological Properties of Tocotrienols: Evidence in Human Studies". Int J Mol Sci. 17 (11). PMC 5133770 . PMID 27792171. doi:10.3390/ijms17111682. 
  14. ^ Galli, F. Azzi, A. Birringer, M. Cook-Mills, J. M. Eggersdorfer, M. Frank, J. Cruciani, G. Lorkowski, S. Ozer, N. K. (2017). "Vitamin E: Emerging aspects and new directions". Free Radic Biol Med. 102: 16-36. doi:10.1016/j.freeradbiomed.2016.09.017. 
  15. ^ Traber MG, Stevens JF; Stevens (2011). "Free Radical Biology and Medicine – Vitamins C and E: Beneficial effects from a mechanistic perspective". Free Radical Biology and Medicine. 51 (5): 1000–13. PMC 3156342 . PMID 21664268. doi:10.1016/j.freeradbiomed.2011.05.017. 
  16. ^ Bracco, P; Oral, E (2011). "Vitamin E-stabilized UHMWPE for total joint implants: A review". Clinical Orthopaedics and Related Research®. 469 (8): 2286–93. PMC 3126938 . PMID 21132413. doi:10.1007/s11999-010-1717-6. 
  17. ^ Piroddi, M. Pilolli, F. Aritomi, M. Galli, F. (2012). "Vitamin E as a functional and biocompatibility modifier of synthetic hemodialyzer membranes: an overview of the literature on vitamin E-modified hemodialyzer membranes". Am J Nephrol. 35: 559-72. doi:10.1159/000338807. 
  18. ^ Schneider C (2005). "Chemistry and biology of vitamin E". Mol Nutr Food Res. 49 (1): 7–30. PMID 15580660. doi:10.1002/mnfr.200400049. 
  19. ^ Moore, K. J.; Sheedy, F. J.; Fisher, E. A. (2013). "Macrophages in atherosclerosis: A dynamic balance". Nature Reviews Immunology. 13 (10): 709–21. PMC 4357520 . PMID 23995626. doi:10.1038/nri3520. 
  20. ^ a b Devaraj S, Hugou I, Jialal I; Hugou; Jialal (2001). "-Tocopherol decreases CD36 expression in human monocyte-derived macrophages". J Lipid Res. 42 (4): 521–527. PMID 11290823. 
  21. ^ Azzi A, Stocker A; Stocker (2000). "Vitamin E: non-antioxidant roles". Prog Lipid Res. 39 (3): 231–255. PMID 10799717. doi:10.1016/S0163-7827(00)00006-0. 
  22. ^ a b Villacorta L, Graça-Souza AV, Ricciarelli R, Zingg JM, Azzi A; Graça-Souza; Ricciarelli; Zingg; Azzi (2003). "α-Tocopherol induces expression of connective tissue growth factor and antagonizes tumor necrosis factor-α-mediated downregulation in human smooth muscle cells". Circ. Res. 92 (1): 104–110. PMID 12522127. doi:10.1161/01.RES.0000049103.38175.1B. 
  23. ^ Muller DP (2010). "Vitamin E and neurological function. Review". Mol. Nutr. Food Res. 54 (5): 710–718. PMID 20183831. doi:10.1002/mnfr.200900460. 
  24. ^ Dowd P, Zheng ZB; Zheng (1995). "On the mechanism of the anticlotting action of vitamin E quinone". Proc Natl Acad Sci U S A. 92 (18): 8171–8175. Bibcode:1995PNAS...92.8171D. PMC 41118 . PMID 7667263. doi:10.1073/pnas.92.18.8171. 
  25. ^ Brigelius-Flohé R, Davies KJ; Davies (2007). "Is vitamin E an antioxidant, a regulator of signal transduction and gene expression, or a 'junk' food? Comments on the two accompanying papers: "Molecular mechanism of alpha-tocopherol action" by A. Azzi and "Vitamin E, antioxidant and nothing more" by M. Traber and J. Atkinson". Free radical biology & medicine. 43 (1): 2–3. PMID 17561087. doi:10.1016/j.freeradbiomed.2007.05.016. 
  26. ^ Atkinson J, Epand RF, Epand RM; Epand; Epand (2008). "Tocopherols and tocotrienols in membranes: a critical review". Free Radical Biology and Medicine. 44 (5): 739–64. PMID 18160049. doi:10.1016/j.freeradbiomed.2007.11.010. 
  27. ^ a b Whitney, Ellie; Sharon Rady Rolfes (2011). Peggy Williams, ed. Understanding Nutrition (Twelfth ed.). California: Wadsworth, Cengage Learning. ISBN 0-538-73465-5. 
  28. ^ Abdala-Valencia, H; Berdnikovs, S; Cook-Mills, J. M. (2013). "Vitamin E isoforms as modulators of lung inflammation". Nutrients. 5 (11): 4347–63. PMC 3847734 . PMID 24184873. doi:10.3390/nu5114347. 
  29. ^ Wang, Y; Chun, O. K.; Song, W. O. (2013). "Plasma and dietary antioxidant status as cardiovascular disease risk factors: A review of human studies". Nutrients. 5 (8): 2969–3004. PMC 3775238 . PMID 23912327. doi:10.3390/nu5082969. 
  30. ^ Brigelius-Flohé R, Traber MG; Traber (1 July 1999). "Vitamin E: function and metabolism". FASEB J. 13 (10): 1145–55. PMID 10385606. 
  31. ^ a b c d e Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes: Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press, 2000.
  32. ^ a b c d e Kowdley KV, Mason JB, Meydani SN, Cornwall S, Grand RJ; Mason; Meydani; Cornwall; Grand (1992). "Vitamin E deficiency and impaired cellular immunity related to intestinal fat malabsorption". Gastroenterology. 102 (6): 2139–42. PMID 1587435. 
  33. ^ Bjelakovic, G; Nikolova, D; Gluud, LL; Simonetti, RG; Gluud, C (14 March 2012). "Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases". The Cochrane database of systematic reviews (3): CD007176. PMID 22419320. doi:10.1002/14651858.CD007176.pub2. 
  34. ^ Haber, David (2006). Health promotion and aging: practical applications for health professionals (4th ed.). New York, NY: Springer Pub. p. 280. ISBN 978-0-8261-8463-4. 
  35. ^ Abner EL, Schmitt FA, Mendiondo MS, Marcum JL, Kryscio RJ; Schmitt; Mendiondo; Marcum; Kryscio (July 2011). "Vitamin E and all-cause mortality: a meta-analysis". Current aging science. 4 (2): 158–70. PMC 4030744 . PMID 21235492. doi:10.2174/1874609811104020158. 
  36. ^ Bin Q, Hu X, Cao Y, Gao F; Hu; Cao; Gao (April 2011). "The role of vitamin E (tocopherol) supplementation in the prevention of stroke. A meta-analysis of 13 randomized controlled trials". Thrombosis and haemostasis. 105 (4): 579–85. PMID 21264448. doi:10.1160/TH10-11-0729. 
  37. ^ Haederle, Michael. "Vitamin E Supplements Raise Risk of Prostate Cancer". Health Discovery. AARP. Retrieved 11 November 2011. 
  38. ^ Olson JH, Erie JC, Bakri SJ; Erie; Bakri (May 2011). "Nutritional supplementation and age-related macular degeneration". Seminars in ophthalmology. 26 (3): 131–6. PMID 21609225. doi:10.3109/08820538.2011.577131. 
  39. ^ Rumbold, Alice; Ota, Erika; Hori, Hiroyuki; Miyazaki, Celine; Crowther, Caroline A. (2015-09-07). "Vitamin E supplementation in pregnancy". The Cochrane Database of Systematic Reviews (9): CD004069. ISSN 1469-493X. PMID 26343254. doi:10.1002/14651858.CD004069.pub3. 
  40. ^ Mathew MC, Ervin AM, Tao J, Davis RM; Ervin; Tao; Davis (2012). "Routine Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract". Cochrane Database Syst Rev. 6 (6): CD004567. PMC 4410744 . PMID 22696344. doi:10.1002/14651858.CD004567.pub2. 
  41. ^ Sidgwick GP, McGeorge D, Bayat A (2015). "A comprehensive evidence-based review on the role of topicals and dressings in the management of skin scarring". Arch. Dermatol. Res. 307 (6): 461–77. PMC 4506744 . PMID 26044054. doi:10.1007/s00403-015-1572-0. 
  42. ^ Material Safety Data Sheet for Vitamin E, accessdate: September 22, 2015
  43. ^ a b c "Vitamin E". 2017. Retrieved 9 May 2017. 
  44. ^ a b Institute of Medicine (2000). "Vitamin E". Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids (PDF). Washington, DC: The National Academies Press. pp. 186–283. 
  45. ^ "USDA List for Vitamin E in Vegetable Oils". US Department of Agriculture, Food Composition Databases. 22 February 2017. 
  46. ^ "Overview on Dietary Reference Values for the EU population as derived by the EFSA Panel on Dietetic Products, Nutrition and Allergies" (PDF). 2017. 
  47. ^ Tolerable Upper Intake Levels For Vitamins And Minerals (PDF), European Food Safety Authority, 2006 
  48. ^ "Federal Register May 27, 2016 Food Labeling: Revision of the Nutrition and Supplement Facts Labels. FR page 33982." (PDF). 
  49. ^ Evans HM, Bishop KS; Bishop (1922). "On the existence of a hitherto unrecognized dietary factor essential for reproduction". Science. 56 (1458): 650–651. Bibcode:1922Sci....56..650E. JSTOR 1647181. PMID 17838496. doi:10.1126/science.56.1458.650. 
  50. ^ Oakes, Elizabeth H. (2007). "Emerson, Gladys Anderson". Encyclopedia of World Scientists. p. 211. ISBN 1438118821{{inconsistent citations}} 
  51. ^ Subcommittee on Vitamin Tolerance, Committee on Animal Nutrition, National Research Council (1987). "Vitamin E, in Vitamin Tolerance of Animals". National Academy of Sciences. Retrieved 22 December 2013. 
  52. ^ a b c Bell EF (1987). "History of vitamin E in infant nutrition". American Journal of Clinical Nutrition. 46 (1 Suppl): 183–186. PMID 3300257. 
  53. ^ Shute, W. E.; Shute, E. V.; et al., Alpha Tocopherol (Vitamin E) in Cardiovascular Disease. Toronto, Ontario, Canada: Ryerson Press, 1945
  54. ^ Vogelsang A, Shute EV; Shute (June 1946). "Effect of vitamin E in coronary heart disease". Nature. 157 (3997): 772. Bibcode:1946Natur.157..772V. PMID 21064771. doi:10.1038/157772b0. 
  55. ^ Shute EV, Vogelsang AB, Skelton FB, Shute WE; Vogelsang (January 1948). "The influence of vitamin E on vascular disease". Surg Gynecol Obstet. 86 (1): 1–8. PMID 18920873. 
  56. ^ Skelton F, Shute E, Skinner HG, Waud RA; Shute; Skinner; Waud (1946). "Antipurpuric Action of A-Tocopherol (Vitamin E)". Science. 103 (2687): 762. PMID 17836459. doi:10.1126/science.103.2687.762-b. 
  57. ^ György P, Rose CS; Rose (1948). "Effect of dietary factors on early mortality and hemoglobinuria in rats following administration of alloxan". Science. 108 (2817): 716–718. Bibcode:1948Sci...108..716G. PMID 17752961. doi:10.1126/science.108.2817.716. 
  58. ^ Gerloczy F (1949). "Clinical and pathological role of d, 1-alpha tocopherol in premature infants; studies on the treatment of scleroedema". Ann Paediatr. 173 (3): 171–86. PMID 18140084. 
  59. ^ Brion LP, Bell EF, Raghuveer TS; Bell; Raghuveer (2003). Brion, Luc P, ed. "Vitamin E supplementation for prevention of morbidity and mortality in preterm infants". Cochrane Database Syst Rev (4): CD003665. PMID 14583988. doi:10.1002/14651858.CD003665. These observations explain why even a small dose of 5 mg of dl-alpha-tocopheryl acetate provided enterally has proven to be more efficient than larger intramuscular doses (30 mg) in treating scleredema (Gerlóczy 1949) 
  60. ^ American Heart Association, 2015
  61. ^ Maruyama, K; Iso, H (2014). Overview of the Role of Antioxidant Vitamins as Protection Against Cardiovascular Disease: Implications of Aging. Available from: Aging: Oxidative Stress and Dietary Antioxidants (1 ed.). New York: Elsevier Inc. p. Chapter 21. 
  62. ^ a b Simon, E; Gariepy, J; Cogny, A; Moatti, A; Simon, A (2001). "Erythrocyte, but not plasma, vitamin E concentration is associated with carotid intima–media thickening in asymptomatic men at risk for cardiovascular disease". Atherosclerosis. 159 (1): 193–200. PMID 11689221. doi:10.1016/s0021-9150(01)00493-2. 
  63. ^ Asplund, K (2002). "Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review". Journal of Internal Medicine. 251 (5): 372–392. PMID 11982737. doi:10.1046/j.1365-2796.2002.00973.x. 
  64. ^ Rimm, E.B; Stampfer, M.J; Ascherio, A (1993). "Vitamin E consumption and the risk of coronary heart disease in men". New England Journal of Medicine. 328 (20): 1450–6. PMID 8479464. doi:10.1056/NEJM199305203282004. 
  65. ^ Ashor, A. W.; Siervo, M; Lara, J; Oggioni, C; Afshar, S; Mathers, J. C. (2015). "Effect of vitamin C and vitamin E supplementation on endothelial function: A systematic review and meta-analysis of randomised controlled trials". British Journal of Nutrition. 113 (8): 1182–94. PMID 25919436. doi:10.1017/S0007114515000227. 
  66. ^ Eidelman, R.S; Hollar, D; Hebert, P.R; Lamas, G.A; Hennekens, C.H (2004). "Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease". Archives of Internal Medicine. 164 (14): 1552–6. PMID 15277288. doi:10.1001/archinte.164.14.1552. 

External linksEdit